Abstract:Since the time of Rudolf Virchow in the 19th century, it has been well-known that cancer-associated inflammation contributes to tumor initiation and progression. However, it remains unclear whether a collapse of the balance between the antitumor immune response via the immunological surveillance system and protumor immunity due to cancer-related inflammation is responsible for cancer malignancy. The majority of inflammatory signals affect tumorigenesis by activating signal transducer and activation of transcription 3 (STAT3) and nuclear factor-κB. Persistent STAT3 activation in malignant cancer cells mediates extremely widespread functions, including cell growth, survival, angiogenesis, and invasion and contributes to an increase in inflammation-associated tumorigenesis. In addition, intracellular STAT3 activation in immune cells causes suppressive effects on antitumor immunity and leads to the differentiation and mobilization of immature myeloid-derived cells and tumor-associated macrophages. In many cancer types, STAT3 does not directly rely on its activation by oncogenic mutations but has important oncogenic and malignant transformation-associated functions in both cancer and stromal cells in the tumor microenvironment (TME). We have reported a series of studies aiming towards understanding the molecular mechanisms underlying the proliferation of various types of tumors involving signal-transducing adaptor protein-2 as an adaptor molecule that modulates STAT3 activity, and we recently found that AT-rich interactive domain-containing protein 5a functions as an mRNA stabilizer that orchestrates an immunosuppressive TME in malignant mesenchymal tumors. In this review, we summarize recent advances in our understanding of the functional role of STAT3 in tumor progression and introduce novel molecular mechanisms of cancer development and malignant transformation involving STAT3 activation that we have identified to date. Finally, we discuss potential therapeutic strategies for cancer that target the signaling pathway to augment STAT3 activity.

The roles of signal transducer and activator of transcription factor 3 in tumor angiogenesis

Role of STAT3 in tumor angiogenesis and radiation sensitivity

Identification of ATAD3A As a Key Regulator in Non-Small Cell Lung Cancer by Promoting STAT3-induced Cell Proliferation and Tumor Angiogenesis

Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery

Effect of Signal Transducer and Activator of Transcription 3 in Neoplasms Invasion and Metastasis

The Pivotal Role of STAT3 in Tumor Occurrence and Progress

Structure, Function, Signaling Pathways and Clinical Therapeutics: the Translational Potential of STAT3 As a Target for Cancer Therapy

STAT3 and Individualized Treatment of Tumors

Signal Transducer and Activator of Transcription 3 and Melanoma

Targeting STAT3 in Cancer Immunotherapy

Signal Transducer and Activator of Transcription 3 Promotes Angiogenesis and Drives Malignant Progression in Glioma

STAT3 and Tumor Therapeutic Target

Multiple regulation pathways and pivotal biological functions of STAT3 in cancer

STAT3 in Tumor Invasion and Metastasis

Stat3 Activation Regulates the Expression of Vascular Endothelial Growth Factor and Human Pancreatic Cancer Angiogenesis and Metastasis

Stat3-regulated Genes and Advances on Tumor Researches

STAT3-targeting RNA Interference Inhibits Pancreatic Cancer Angiogenesis in Vitro and in Vivo

Roles Of Stat3 In Regulation Of Emt-Mediated Phenotypic Plasticity And Its Effects On Circulating Tumor Cells And Tumor Invasion And Metastases

Central Roles of STAT3-Mediated Signals in Onset and Development of Cancers: Tumorigenesis and Immunosurveillance

STAT3-YAP/TAZ signaling in endothelial cells promotes tumor angiogenesis

STAT3: The Key Player in The Network of Inflammation and Cancer